ArticleInternational journal of pharmaceutics2025
Binary lipid system-based granules with undissolved drug crystals enhance oral bioavailability by preventing degradation and improving permeability.
Article in International journal of pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Influences of formulations and administration routes on docetaxel tissue distribution in mice.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Conventional oral drug delivery systems, such as lipid-based formulations and nanoparticles, require drugs to fully dissolve in excipients to improve solubility and bioavailability. However, many drugs, including olmesartan medoxomil (OLM), an ester prodrug for hypertension, have low solubility in water, lipids, and surfactants, resulting in low drug loading (e.g. 1 ∼ 2 % drug loading) and formulation challenges. Premature degradation of ester prodrugs is also a major factor contributing to the low bioavailability of prodrugs. This study developed OLM lipid-solid granules (LSG) by coating OLM crystals with a binary lipid system (BLS) composed of one lipid and one water-soluble surfactant only. The OLM granules achieved 10 % drug loading and increased relative bioavailability to 625 %, surpassing all previously reported formulations containing dissolved OLM. Extensive in vitro studies, including two-step dissolution and Caco-2 cell assays with and without esterase, demonstrated that OLM LSG protected OLM from esterase-mediated hydrolysis and enhanced drug uptake and permeability. Pharmacokinetics and tissue distribution confirmed enhanced small intestine absorption. This novel approach introduces a transformative concept of coating drug crystals with a BLS in solid granules to enhance oral absorption and eliminates the need to dissolve drugs in excipients. It represents a fundamental shift in the use of lipids and surfactants, offering a promising platform for delivering prodrugs with low solubility and susceptibility to hydrolysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.